文化大學機構典藏 CCUR:Item 987654321/30607
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 47249/51115 (92%)
Visitors : 14027280      Online Users : 271
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version


    Please use this identifier to cite or link to this item: https://irlib.pccu.edu.tw/handle/987654321/30607


    Title: Enhanced Control of Bladder-Associated Tumors Using Shrimp Anti-Lipopolysaccharide Factor (SALF) Antimicrobial Peptide as a Cancer Vaccine Adjuvant in Mice
    Authors: Huang, Han-Ning
    Rajanbabu, Venugopal
    Pan, Chieh-Yu
    Chan, Yi-Lin
    Chen, Jyh-Yih
    Wu, Chang-Jer
    Contributors: Dept Life Sci
    Keywords: SALF
    antimicrobial
    peptide
    MBT-2
    bladder tumor
    cancer vaccine
    bladder tumor
    Date: 2015-05
    Issue Date: 2015-10-23 14:08:44 (UTC+8)
    Abstract: Shrimp anti-lipopolysaccharide factor (SALF) is an antimicrobial peptide with reported anticancer activities, such as suppression of tumor progression. In this study, we prepared a potential cancer vaccine comprised of SALF in conjunction with the cell lysate of inactivated murine bladder carcinoma cells (MBT-2), and evaluated its efficacy in a mouse tumor model. Our study shows that SALF added to cell culture media inhibits growth progression of MBT-2, and that SALF together with inactivated MBT-2 lysate elevates the level of inflammasome activity, and modulates the levels of IL-1, MCP-1, IL-6, IL-12, and TNF- in mouse macrophages. Immunization of 7, 14, and 21 day-old mice with the vaccine prevented growth of MBT-2 cell-mediated tumors. The vaccine was found to enhance expression of T-cell, cytotoxic T cells, and NK cells in the immunized mice groups. Recruitment of macrophages, T-helper cells, and NK cells was enhanced, but levels of VEGF were decreased in immunized mice. This report provides empirical evidence that our SALF as vaccine adjuvant enhances antitumor immunity in mice.
    Relation: MARINE DRUGS 卷: 13 期: 5 頁碼: 3241-3258
    Appears in Collections:[Department of Biology ] journal articles

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML382View/Open


    All items in CCUR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback